BioNTech, CureVac bag $745M in German funding for COVID-19 vaccine hopefuls
Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time-consuming and costly process. In order to get both over the finish line, the German government is making a big investment in both candidates’ development. The German government has awarded the mRNA-based vaccine makers a combined… Read More »